Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PrEPTECH Phase 2 Study: Randomized-Controlled Trial of a Telehealth Intervention Delivering PrEP to Young Men Who Have Sex With Men and Transgender Women

NCT04902820 is registered in ClinicalTrials.gov with ETR Associates as lead sponsor.

NCT NCT04902820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04902820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PrEPTECH Phase 2 Study: Randomized-Controlled Trial of a Telehealth Intervention Delivering PrEP to Young Men Who Have Sex With Men and Transgender Women
Lead sponsor
ETR Associates
Phase
Not applicable
Overall status
Completed
Start date
February 12, 2022
Completion date
June 30, 2023
Enrollment
229 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, pre-exposure prophylaxis, telemedicine